Selected research
Industry Research
Companion Animal Anti-infectives Industry Research Report 2026
Market perspective
The global Companion Animal Anti-infectives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Companion Animal Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Companion Animal Anti-infectives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Companion Animal Anti-infectives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Companion Animal Anti-infectives include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Chanelle, Elanco, Vetoquinol, Virbac, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Companion Animal Anti-infectives market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Companion Animal Anti-infectives Market by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Chanelle
Elanco
Vetoquinol
Virbac
Bayer
Merck
Zoetis
Companion Animal Anti-infectives Segment by Type
Injection
Unguent
Companion Animal Anti-infectives Segment by Application
Dogs
Cats
Other
Companion Animal Anti-infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Anti-infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Anti-infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Anti-infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Companion Animal Anti-infectives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Companion Animal Anti-infectives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Companion Animal Anti-infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Unguent
Applications
- Dogs
- Cats
- Other
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Chanelle
- Elanco
- Vetoquinol
- Virbac
- Bayer
- Merck
- Zoetis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Companion Animal Anti-infectives Market Size (2021-2032)
- 2.2.2 Global Companion Animal Anti-infectives Sales (2021-2032)
- 2.2.3 Global Companion Animal Anti-infectives Market Average Price (2021-2032)
- 2.3 Companion Animal Anti-infectives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Unguent
- 2.4 Companion Animal Anti-infectives by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dogs
- 2.4.3 Cats
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Companion Animal Anti-infectives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Companion Animal Anti-infectives Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Companion Animal Anti-infectives Revenue of Manufacturers (2021-2026)
- 3.4 Global Companion Animal Anti-infectives Average Price by Manufacturers (2021-2026)
- 3.5 Global Companion Animal Anti-infectives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Companion Animal Anti-infectives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Companion Animal Anti-infectives, Product Type & Application
- 3.8 Global Manufacturers of Companion Animal Anti-infectives, Established Date
- 3.9 Global Companion Animal Anti-infectives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bimeda Animal Health
- 4.1.1 Bimeda Animal Health Company Information
- 4.1.2 Bimeda Animal Health Business Overview
- 4.1.3 Bimeda Animal Health Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bimeda Animal Health Companion Animal Anti-infectives Product Portfolio
- 4.1.5 Bimeda Animal Health Recent Developments
- 4.2 Boehringer Ingelheim
- 4.2.1 Boehringer Ingelheim Company Information
- 4.2.2 Boehringer Ingelheim Business Overview
- 4.2.3 Boehringer Ingelheim Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer Ingelheim Companion Animal Anti-infectives Product Portfolio
- 4.2.5 Boehringer Ingelheim Recent Developments
- 4.3 Ceva Sante Animale
- 4.3.1 Ceva Sante Animale Company Information
- 4.3.2 Ceva Sante Animale Business Overview
- 4.3.3 Ceva Sante Animale Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ceva Sante Animale Companion Animal Anti-infectives Product Portfolio
- 4.3.5 Ceva Sante Animale Recent Developments
- 4.4 Chanelle
- 4.4.1 Chanelle Company Information
- 4.4.2 Chanelle Business Overview
- 4.4.3 Chanelle Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Chanelle Companion Animal Anti-infectives Product Portfolio
- 4.4.5 Chanelle Recent Developments
- 4.5 Elanco
- 4.5.1 Elanco Company Information
- 4.5.2 Elanco Business Overview
- 4.5.3 Elanco Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Elanco Companion Animal Anti-infectives Product Portfolio
- 4.5.5 Elanco Recent Developments
- 4.6 Vetoquinol
- 4.6.1 Vetoquinol Company Information
- 4.6.2 Vetoquinol Business Overview
- 4.6.3 Vetoquinol Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Vetoquinol Companion Animal Anti-infectives Product Portfolio
- 4.6.5 Vetoquinol Recent Developments
- 4.7 Virbac
- 4.7.1 Virbac Company Information
- 4.7.2 Virbac Business Overview
- 4.7.3 Virbac Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Virbac Companion Animal Anti-infectives Product Portfolio
- 4.7.5 Virbac Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Companion Animal Anti-infectives Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 Merck
- 4.9.1 Merck Company Information
- 4.9.2 Merck Business Overview
- 4.9.3 Merck Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck Companion Animal Anti-infectives Product Portfolio
- 4.9.5 Merck Recent Developments
- 4.10 Zoetis
- 4.10.1 Zoetis Company Information
- 4.10.2 Zoetis Business Overview
- 4.10.3 Zoetis Companion Animal Anti-infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zoetis Companion Animal Anti-infectives Product Portfolio
- 4.10.5 Zoetis Recent Developments
5 Global Companion Animal Anti-infectives Market Scenario by Region
- 5.1 Global Companion Animal Anti-infectives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Companion Animal Anti-infectives Sales by Region: 2021-2032
- 5.2.1 Global Companion Animal Anti-infectives Sales by Region: 2021-2026
- 5.2.2 Global Companion Animal Anti-infectives Sales by Region: 2027-2032
- 5.3 Global Companion Animal Anti-infectives Revenue by Region: 2021-2032
- 5.3.1 Global Companion Animal Anti-infectives Revenue by Region: 2021-2026
- 5.3.2 Global Companion Animal Anti-infectives Revenue by Region: 2027-2032
- 5.4 North America Companion Animal Anti-infectives Market Facts & Figures by Country
- 5.4.1 North America Companion Animal Anti-infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Companion Animal Anti-infectives Sales by Country (2021-2032)
- 5.4.3 North America Companion Animal Anti-infectives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Companion Animal Anti-infectives Market Facts & Figures by Country
- 5.5.1 Europe Companion Animal Anti-infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Companion Animal Anti-infectives Sales by Country (2021-2032)
- 5.5.3 Europe Companion Animal Anti-infectives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Companion Animal Anti-infectives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Companion Animal Anti-infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Companion Animal Anti-infectives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Companion Animal Anti-infectives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Companion Animal Anti-infectives Market Facts & Figures by Country
- 5.7.1 South America Companion Animal Anti-infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Companion Animal Anti-infectives Sales by Country (2021-2032)
- 5.7.3 South America Companion Animal Anti-infectives Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Companion Animal Anti-infectives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Companion Animal Anti-infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Companion Animal Anti-infectives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Companion Animal Anti-infectives Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Companion Animal Anti-infectives Sales by Type (2021-2032)
- 6.1.1 Global Companion Animal Anti-infectives Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Companion Animal Anti-infectives Sales Market Share by Type (2021-2032)
- 6.2 Global Companion Animal Anti-infectives Revenue by Type (2021-2032)
- 6.2.1 Global Companion Animal Anti-infectives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Companion Animal Anti-infectives Revenue Market Share by Type (2021-2032)
- 6.3 Global Companion Animal Anti-infectives Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Companion Animal Anti-infectives Sales by Application (2021-2032)
- 7.1.1 Global Companion Animal Anti-infectives Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Companion Animal Anti-infectives Sales Market Share by Application (2021-2032)
- 7.2 Global Companion Animal Anti-infectives Revenue by Application (2021-2032)
- 7.2.1 Global Companion Animal Anti-infectives Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Companion Animal Anti-infectives Revenue Market Share by Application (2021-2032)
- 7.3 Global Companion Animal Anti-infectives Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Companion Animal Anti-infectives Value Chain Analysis
- 8.1.1 Companion Animal Anti-infectives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Companion Animal Anti-infectives Production Mode & Process
- 8.2 Companion Animal Anti-infectives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Companion Animal Anti-infectives Distributors
- 8.2.3 Companion Animal Anti-infectives Customers
9 Global Companion Animal Anti-infectives Analyzing Market Dynamics
- 9.1 Companion Animal Anti-infectives Industry Trends
- 9.2 Companion Animal Anti-infectives Industry Drivers
- 9.3 Companion Animal Anti-infectives Industry Opportunities and Challenges
- 9.4 Companion Animal Anti-infectives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst